Maryland, August 3, 2005 --
Chindex International, Inc. (NASDAQ: CHDX
- News ) the leading independent American
provider of Western healthcare products distribution and healthcare
services in the People's Republic of China, announced that it intends
to release its financial results for the first quarter ended June
30, 2005, prior to market opening on Wednesday, August 10, 2005.
management will also host a conference call on Thursday, August 11,
2005 at 11:00 a.m. Eastern Time ( 11:00 p.m. China time; 8:00 a.m.
Pacific Time) to discuss its financial results.
participate, international callers dial 706-643-0393, domestic callers
dial 800-451-9102 approximately 10 minutes before the conference call
is scheduled to begin. The pass code for the call is 8391014
telephone replay will be available two hours after the call at (international)
706-645-9291 and (domestic) 800-642-1687,
pass code 8391014 , and continue
to be available through August 18, 2005.
Chindex International, Inc.
is an American company operating in several healthcare sectors of
the Chinese marketplace, including Hong
Kong . It provides
representative and distribution services to a number of major multinational
companies, including Siemens AG (ultrasound systems) and Guidant (interventional
cardiology products including stents, balloon catheters and guide
wires). Its distribution channels to the retail pharmacy industry
were developed through a relationship with a major multinational cosmetics
manufacturer. It also provides healthcare services through the operations
of its two private hospitals in China
. With twenty-four
years of experience, over 1,000 employees and operations in the United
States, China and Hong Kong, the Company's strategy is to expand its
cross'cultural reach by providing leading edge technologies, quality
products and services to Greater China:s professional communities.
Further company information may be found at the Company's websites
www.chindex.com and www.unitedfamilyhospitals.com
statements in this press release that relate to future plans, events
or performance are forward-looking statements that involve risks and
uncertainties, including risks associated with uncertainties pertaining
to the Company's (i) introduction of new products, (ii) performance
goals, including successful conclusion of efforts to secure governmen-backed
financing and successful implementation of such financing, (iii) future
events and earnings, including revenues from the Company's developmental
businesses such as healthcare services, (iv) markets, including growth
in demand in China for the Company's products and services, and (v)
proposed new operations, including expansion of its healthcare services
business. Actual results, events and performance may differ materially.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. The Company undertakes
no obligation to release publicly the result of any revisions to these
forward-looking statements that may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated